Clinical trial
The Pharmacokinetics and Safety of IDV/r With NRTIs in HIV/TB Co-infected…
NCT00411996 · The HIV Netherlands Australia Thailand Research Collaboration, Other · Completed
Key facts
| NCT number | NCT00411996 |
|---|---|
| Title | The Pharmacokinetics and Safety of IDV/r With NRTIs in HIV/TB Co-infected Patients Receiving Rifampicin |
| Official title | The Pharmacokinetics and Safety of Ritonavir-boosted Indinavir 600/100mg Bid Combined With NRTIs in ARV naïve HIV/TB Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis Therapy |
| Lead sponsor | The HIV Netherlands Australia Thailand Research Collaboration, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections, Tuberculosis |
| Intervention type | Drug |
| Interventions | indinavir/ritonavir |
| Enrollment | 20 |
| Start date | Dec 1, 2006 |
| Primary completion | Oct 1, 2008 |
| Completion | Dec 1, 2009 |
| First posted | Dec 15, 2006 |
| Last update posted | Jul 17, 2020 |
| Countries | Thailand |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: